首页 › 基金 › LUMINUS MANAGEMENT LLC › VTGN
LUMINUS MANAGEMENT LLC 对 VTGN 的持仓历史
VISTAGEN THERAPEUTICS INC · 医疗保健
LUMINUS MANAGEMENT LLC 在 Q2 2026 的 13F 申报中披露持有 VTGN(VISTAGEN THERAPEUTICS INC)403,115 股,市值约 US$91K,约占其申报组合的 0.06%,在其申报持仓中市值排名第 29 位。 LUMINUS MANAGEMENT LLC 最近 3 个申报季度中有 3 个季度披露了 VTGN 持仓,最早可追溯至 Q4 2025。
最后更新: 2026-10-24 · 来源: SEC EDGAR Form 13F-HR
LUMINUS MANAGEMENT LLC 对 VTGN 的持仓演变
LUMINUS MANAGEMENT LLC 于 Q4 2025 首次披露 VTGN 持仓:350,000 股(约 US$232K)。 在 3 次申报中,LUMINUS MANAGEMENT LLC 2 次增持、0 次减持、0 次保持不变。 最近一期申报(Q2 2026)显示持股 403,115 股、市值约 US$91K,环比增持 7,062 股。。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q4 2025 | 350.00K | $231.66K | 新进 |
| Q1 2026 | 396.05K | $226.34K | 增持 |
| Q2 2026 | 403.12K | $91.10K | 增持 |
折线上的点按变动类型着色;缺失季度表示该季未申报持仓。
关于 VTGN 与 13F 数据
VTGN(VISTAGEN THERAPEUTICS INC)属于医疗保健行业。我们追踪的基金中还有 8 只申报持有 VTGN,申报仓位最大的包括:Commodore Capital LP (US$630K)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
更多关于 LUMINUS MANAGEMENT LLC
常见问题
How long has LUMINUS MANAGEMENT LLC held VTGN?
LUMINUS MANAGEMENT LLC has disclosed VTGN holdings in 3 of the last 3 reported quarters, going back to Q4 2025.
What is LUMINUS MANAGEMENT LLC's current position in VTGN?
As of Q2 2026, LUMINUS MANAGEMENT LLC holds 403.12K shares of VTGN (VISTAGEN THERAPEUTICS INC), valued at $91.10K, representing 0.06% of its reported portfolio and ranking #29.
Has LUMINUS MANAGEMENT LLC been buying or selling VTGN?
In the latest 13F filing (Q2 2026), LUMINUS MANAGEMENT LLC increased its position in VTGN.
Which other funds hold VTGN?
Other major institutional holders of VTGN include Commodore Capital LP, among 8 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.